Avantor Inc
AVTR13.440USD
-0.360-2.61%
Close 07/31, 16:00（ET）Quotes delayed by 15 min
9.16BMarket Cap
12.80P/E TTM
More Details of Avantor Inc Company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Company Info
Ticker SymbolAVTR
Company nameAvantor Inc
IPO dateMay 17, 2019
Founded at2017
CEOMr. Michael Stubblefield
Number of employees13500
Security typeOrdinary Share
Fiscal year-endMay 17
Address- -
City- -
Stock exchangeNYSE Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolAVTR
IPO dateMay 17, 2019
Founded at2017
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Director
Independent Director
39.83K
+75.24%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Shareholders
Shareholders
Proportion
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.11%
Investment Advisor/Hedge Fund
37.65%
Hedge Fund
2.48%
Pension Fund
2.36%
Private Equity
2.06%
Research Firm
1.61%
Bank and Trust
1.42%
Family Office
1.41%
Individual Investor
1.37%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1129
699.68M
102.68%
-68.06M
2025Q1
1158
711.07M
104.35%
-68.24M
2024Q4
1156
702.95M
103.24%
-73.39M
2024Q3
1145
700.88M
103.10%
-38.62M
2024Q2
1147
666.63M
98.14%
-52.63M
2024Q1
1136
657.58M
96.83%
-81.17M
2023Q4
1152
657.17M
97.18%
-48.15M
2023Q3
1143
643.33M
95.20%
-49.55M
2023Q2
1149
625.74M
92.71%
-61.95M
2023Q1
1138
629.07M
93.23%
-29.97M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
100.26M
14.71%
+1.12M
+1.13%
Mar 31, 2025
The Vanguard Group, Inc.
64.63M
9.48%
+956.59K
+1.50%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
56.00M
8.22%
+599.07K
+1.08%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
41.97M
6.16%
+608.81K
+1.47%
Mar 31, 2025
Barrow Hanley Global Investors
30.26M
4.44%
-270.10K
-0.88%
Mar 31, 2025
State Street Global Advisors (US)
23.60M
3.46%
+290.54K
+1.25%
Mar 31, 2025
Janus Henderson Investors
18.71M
2.75%
+571.10K
+3.15%
Mar 31, 2025
1832 Asset Management L.P.
18.13M
2.66%
+8.58M
+89.84%
Mar 31, 2025
UBS Financial Services, Inc.
16.26M
2.39%
+12.12M
+292.80%
Mar 31, 2025
Manulife Investment Management (North America) Limited
14.03M
2.06%
+4.88M
+53.25%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
Otter Creek Focus Strategy ETF
3.3%
First Trust Health Care Alphadex Fund
1.49%
John Hancock Fundamental All Cap Core ETF
1.24%
BNY Mellon Women's Opportunities ETF
0.95%
Amplify AI Powered Equity ETF
0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.68%
SPDR S&P 400 Mid Cap Value ETF
0.68%
First Trust Large Cap Value Alphadex Fund
0.59%
Pacer Trendpilot US Mid Cap ETF
0.39%
First Trust Large Cap Core Alphadex Fund
0.36%
View more
Otter Creek Focus Strategy ETF
Proportion3.3%
First Trust Health Care Alphadex Fund
Proportion1.49%
John Hancock Fundamental All Cap Core ETF
Proportion1.24%
BNY Mellon Women's Opportunities ETF
Proportion0.95%
Amplify AI Powered Equity ETF
Proportion0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proportion0.68%
SPDR S&P 400 Mid Cap Value ETF
Proportion0.68%
First Trust Large Cap Value Alphadex Fund
Proportion0.59%
Pacer Trendpilot US Mid Cap ETF
Proportion0.39%
First Trust Large Cap Core Alphadex Fund
Proportion0.36%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
